OpenURL Connection Search

Select item for more details and to access through your institution.

Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group Study.
Published in:
JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 13, p. 926
By:
- Zalupski, Mark;
- Metch, Barbara;
- Balcerzak, Stanley;
- Fletcher, William S.;
- Chapman, Robert;
- Bonnet, John D.;
- Weiss, Geoffrey R.;
- Ryan, James;
- Benjamin, Robert S.;
- Baker, Laurence H.
Publication type:
Article
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas.
Published in:
1986
By:
- Saiki, John H.;
- Baker, Laurence H.;
- Rivkin, Saul E.;
- Shahbender, Salah;
- Fletcher, William S.;
- Athens, John W.;
- Balcerzak, Stanley P.;
- Bonnet, John D.;
- Saiki, J H;
- Baker, L H;
- Rivkin, S E;
- Shahbender, S;
- Fletcher, W S;
- Athens, J W;
- Balcerzak, S P;
- Bonnet, J D
Publication type:
journal article
Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study.
Published in:
1983
By:
- Bukowski, Ronald M.;
- Balcerzak, Stanley P.;
- O'Bryan, Robert M.;
- Bonnet, John D.;
- Chen, T. Timothy;
- Bukowski, R M;
- Balcerzak, S P;
- O'Bryan, R M;
- Bonnet, J D;
- Chen, T T
Publication type:
journal article
Bronchogenic carcinoma presenting as spontaneous pneumothorax: case reports with review of literature.
Published in:
1977
By:
- Yeung, Kai-Yiu;
- Bonnet, John D.;
- Yeung, K Y;
- Bonnet, J D
Publication type:
journal article
Prognostic factors in multiple myeloma.
Published in:
Cancer (0008543X), 1975, v. 36, n. 4, p. 1192, doi. 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO;2-I
By:
- Alexanian, Raymond;
- Balcerzak, Stanley;
- Bonnet, John D.;
- Gehan, Edmund A.;
- Haut, Arthur;
- Hewlett, James S.;
- Monto, Raymond W.
Publication type:
Article
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study.
Published in:
1995
By:
- Dalton, William S.;
- Crowley, John J.;
- Salmon, Sydney S.;
- Grogan, Thomas M.;
- Laufman, Leslie Rodgers;
- Weiss, Geoffrey R.;
- Bonnet, John D.;
- Dalton, W S;
- Crowley, J J;
- Salmon, S S;
- Grogan, T M;
- Laufman, L R;
- Weiss, G R;
- Bonnet, J D
Publication type:
journal article

Found: 6

Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group Study.

A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas.

Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study.

Bronchogenic carcinoma presenting as spontaneous pneumothorax: case reports with review of literature.

Prognostic factors in multiple myeloma.

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study.